Oyepeju Abioye
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
Oyepeju Abioye
Jun 8, 2024, 15:41 |
Blog
Oyepeju Abioye: I got answers to something from incredible Arya Roy
Oyepeju Abioye, Internal Medicine Resident at Allegheny Health Network, recently shared on X: "From a…
Jun 2, 2024, 22:56 |
Blog
Oyepeju Abioye: Electrifying speech by Ophira Ginsburg at The Lancet Commission on Women, Power and Cancer
Ophira Ginsburg shared a post by Oyepeju Abioye, Research Assistant at Florez Lab, on X: "Thanks for your…
Apr 17, 2024, 05:11 |
Blog
Oyepeju Abioye: Humbled to be featured in the Rising Stars section of the April 2024 Issue of the Oncology Compass Digest
Oyepeju Abioye, Research Assistant at Florez Lab, shared a post on X: "What a great way…
Apr 11, 2024, 17:15 |
Blog
Oyepeju Abioye: 'Precision Immuno-Oncology in NSCLC through Gender Equity Lenses', published in MDPI
Oyepeju Abioye, Oncology Clinical Research Assistant at Florez Laboratory of Dana-Farber Cancer Institute, shared on X:…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube